Pfizer
Sami Huilla serves as the Omnichannel Lead for the Western Europe Cluster at Pfizer, overseeing operations in 12 countries and leading a team of 50 marketers to drive omnichannel excellence. With extensive experience in management roles, Sami has held multiple positions within Pfizer, including Managing Director and Country Manager for Finland, and Nordics cluster lead for the Hospital Business Unit, contributing significantly to revenue growth in the region. Sami's background includes directing finance for various divisions across Europe and the Asia Pacific, shaping business strategies, and managing substantial P&L responsibilities. In addition to current roles at Pfizer, Sami is a board member for Lääketeollisuus ry / Pharma Industry Finland and Pharmaca Health Intelligence. Sami holds a Master of Science in Economy with a focus on Finance from LUT University and additional education from École Supérieure de Commerce Et de Management.
This person is not in any teams
This person is not in any offices
Pfizer
614 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.